Name: Global Daclatasvir Market Insights and Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.6 (181 reviews)

Global Daclatasvir Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The research report on global Daclatasvir Market published by Extent Research covers all the market details for the forecast period. Primarily, the report considers some essential factors that accounts for the growth and development of the market. The Daclatasvir market report sheds light on the major interferences and challenges. The document provides a clear picture of the future market scope and competitive market scenarios for gaining complete knowledge about the market growth rate during the forecast period. Furthermore, the report studies the vital growth aspects such as growth stimulators, market valuation, regional segmentation, and market competitiveness among the key players. Some of the major players analyzed in the report include Bristol-Myers Squibb, Natco Pharma, Zydus Cadila, Hetero Drugs, Dr Reddy’s Laboratories, Cipla, Mylan, Abbott, Emcure Pharmaceuticals, Torrent Pharmaceuticals, Biocon, .

Data provided by Extent Research. Source: https://www.extentresearch.com/daclatasvir-market

The latest research report on the Daclatasvir market provides a complete analysis of the market sphere and various market segmentation. The research report clearly portrays the substantial growth that the Daclatasvir market is expected to attain during the forecast period. The study also compiles and details all concerning market size, market growth rate, growth drivers, and key market trends. A complete examination of the important growth influencers of the Daclatasvir industry in the next few years is also represented in the report.

The global Daclatasvir market report also encompasses the regional analysis including North America, Europe, Asia Pacific, Latin America, Middle East & Africa, to offer the complete regional development status. Additionally, the report also provides necessary recommendations and suggestions for the Daclatasvir market players in order to attain a competitive edge in various regions.

Segmentation of the Global Daclatasvir Market:

By Product type

30mg Tables, 60mg Tables,

by Application

Hepatitis C Virus (HCV) Genotype 1, Hepatitis C Virus (HCV) Genotype 3, Hepatitis C Virus (HCV) Genotype 4,

Major factors covered in the research report:

The report provides all the vital and accurate figures required to gain better understanding of the market revenue, share, and volume.
Market overview, competitive landscape, costing analysis, consumption rate, export/import details, and market strategies.
A complete detail of the growth rate over the forecast period is depicted in the Daclatasvir market report.
All the aspects including market regional development status and market competitiveness are also presented in the statistical format.
Other essential data including challenges, opportunities, risks, latest developments, and future scope of the market are accurately covered in the report.
The report covers key business strategies, growth stimulators, and statistical data that will help market players take crucial business decisions.

Report Scope and Market Segmentation

ATTRIBUTES	Global Daclatasvir Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Daclatasvir Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Daclatasvir Product Introduction
    1.2 Market by Type
        1.2.1 Global Daclatasvir Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 30mg Tables
        1.2.3 60mg Tables
    1.3 Market by Application
        1.3.1 Global Daclatasvir Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Hepatitis C Virus (HCV) Genotype 1
        1.3.3 Hepatitis C Virus (HCV) Genotype 3
        1.3.4 Hepatitis C Virus (HCV) Genotype 4
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Daclatasvir Sales Estimates and Forecasts 2017-2035
    2.2 Global Daclatasvir Revenue Estimates and Forecasts 2017-2035
    2.3 Global Daclatasvir Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Daclatasvir Sales by Region
        2.4.1 Global Daclatasvir Sales by Region (2017-2022)
        2.4.2 Global Sales Daclatasvir by Region (2023-2035)
    2.5 Global Daclatasvir Revenue by Region
        2.5.1 Global Daclatasvir Revenue by Region (2017-2022)
        2.5.2 Global Daclatasvir Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Daclatasvir Sales by Manufacturers
        3.1.1 Global Top Daclatasvir Manufacturers by Sales (2017-2022)
        3.1.2 Global Daclatasvir Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Daclatasvir in 2021
    3.2 Global Daclatasvir Revenue by Manufacturers
        3.2.1 Global Daclatasvir Revenue by Manufacturers (2017-2022)
        3.2.2 Global Daclatasvir Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Daclatasvir Revenue in 2021
    3.3 Global Daclatasvir Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Daclatasvir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Daclatasvir Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Daclatasvir Sales by Type
        4.1.1 Global Daclatasvir Historical Sales by Type (2017-2022)
        4.1.2 Global Daclatasvir Forecasted Sales by Type (2023-2035)
        4.1.3 Global Daclatasvir Sales Market Share by Type (2017-2035)
    4.2 Global Daclatasvir Revenue by Type
        4.2.1 Global Daclatasvir Historical Revenue by Type (2017-2022)
        4.2.2 Global Daclatasvir Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Daclatasvir Revenue Market Share by Type (2017-2035)
    4.3 Global Daclatasvir Price by Type
        4.3.1 Global Daclatasvir Price by Type (2017-2022)
        4.3.2 Global Daclatasvir Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Daclatasvir Sales by Application
        5.1.1 Global Daclatasvir Historical Sales by Application (2017-2022)
        5.1.2 Global Daclatasvir Forecasted Sales by Application (2023-2035)
        5.1.3 Global Daclatasvir Sales Market Share by Application (2017-2035)
    5.2 Global Daclatasvir Revenue by Application
        5.2.1 Global Daclatasvir Historical Revenue by Application (2017-2022)
        5.2.2 Global Daclatasvir Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Daclatasvir Revenue Market Share by Application (2017-2035)
    5.3 Global Daclatasvir Price by Application
        5.3.1 Global Daclatasvir Price by Application (2017-2022)
        5.3.2 Global Daclatasvir Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Daclatasvir Market Size by Type
        6.1.1 North America Daclatasvir Sales by Type (2017-2035)
        6.1.2 North America Daclatasvir Revenue by Type (2017-2035)
    6.2 North America Daclatasvir Market Size by Application
        6.2.1 North America Daclatasvir Sales by Application (2017-2035)
        6.2.2 North America Daclatasvir Revenue by Application (2017-2035)
    6.3 North America Daclatasvir Market Size by Country
        6.3.1 North America Daclatasvir Sales by Country (2017-2035)
        6.3.2 North America Daclatasvir Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Daclatasvir Market Size by Type
        7.1.1 Europe Daclatasvir Sales by Type (2017-2035)
        7.1.2 Europe Daclatasvir Revenue by Type (2017-2035)
    7.2 Europe Daclatasvir Market Size by Application
        7.2.1 Europe Daclatasvir Sales by Application (2017-2035)
        7.2.2 Europe Daclatasvir Revenue by Application (2017-2035)
    7.3 Europe Daclatasvir Market Size by Country
        7.3.1 Europe Daclatasvir Sales by Country (2017-2035)
        7.3.2 Europe Daclatasvir Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Daclatasvir Market Size by Type
        8.1.1 Asia Pacific Daclatasvir Sales by Type (2017-2035)
        8.1.2 Asia Pacific Daclatasvir Revenue by Type (2017-2035)
    8.2 Asia Pacific Daclatasvir Market Size by Application
        8.2.1 Asia Pacific Daclatasvir Sales by Application (2017-2035)
        8.2.2 Asia Pacific Daclatasvir Revenue by Application (2017-2035)
    8.3 Asia Pacific Daclatasvir Market Size by Region
        8.3.1 Asia Pacific Daclatasvir Sales by Region (2017-2035)
        8.3.2 Asia Pacific Daclatasvir Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Daclatasvir Market Size by Type
        9.1.1 Latin America Daclatasvir Sales by Type (2017-2035)
        9.1.2 Latin America Daclatasvir Revenue by Type (2017-2035)
    9.2 Latin America Daclatasvir Market Size by Application
        9.2.1 Latin America Daclatasvir Sales by Application (2017-2035)
        9.2.2 Latin America Daclatasvir Revenue by Application (2017-2035)
    9.3 Latin America Daclatasvir Market Size by Country
        9.3.1 Latin America Daclatasvir Sales by Country (2017-2035)
        9.3.2 Latin America Daclatasvir Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Daclatasvir Market Size by Type
        10.1.1 Middle East and Africa Daclatasvir Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Daclatasvir Revenue by Type (2017-2035)
    10.2 Middle East and Africa Daclatasvir Market Size by Application
        10.2.1 Middle East and Africa Daclatasvir Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Daclatasvir Revenue by Application (2017-2035)
    10.3 Middle East and Africa Daclatasvir Market Size by Country
        10.3.1 Middle East and Africa Daclatasvir Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Daclatasvir Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bristol-Myers Squibb
        11.1.1 Bristol-Myers Squibb Corporation Information
        11.1.2 Bristol-Myers Squibb Overview
        11.1.3 Bristol-Myers Squibb Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bristol-Myers Squibb Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bristol-Myers Squibb Recent Developments
    11.2 Natco Pharma
        11.2.1 Natco Pharma Corporation Information
        11.2.2 Natco Pharma Overview
        11.2.3 Natco Pharma Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Natco Pharma Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Natco Pharma Recent Developments
    11.3 Zydus Cadila
        11.3.1 Zydus Cadila Corporation Information
        11.3.2 Zydus Cadila Overview
        11.3.3 Zydus Cadila Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Zydus Cadila Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Zydus Cadila Recent Developments
    11.4 Hetero Drugs
        11.4.1 Hetero Drugs Corporation Information
        11.4.2 Hetero Drugs Overview
        11.4.3 Hetero Drugs Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Hetero Drugs Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Hetero Drugs Recent Developments
    11.5 Dr Reddy's Laboratories
        11.5.1 Dr Reddy's Laboratories Corporation Information
        11.5.2 Dr Reddy's Laboratories Overview
        11.5.3 Dr Reddy's Laboratories Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Dr Reddy's Laboratories Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Dr Reddy's Laboratories Recent Developments
    11.6 Cipla
        11.6.1 Cipla Corporation Information
        11.6.2 Cipla Overview
        11.6.3 Cipla Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Cipla Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Cipla Recent Developments
    11.7 Mylan
        11.7.1 Mylan Corporation Information
        11.7.2 Mylan Overview
        11.7.3 Mylan Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Mylan Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Mylan Recent Developments
    11.8 Abbott
        11.8.1 Abbott Corporation Information
        11.8.2 Abbott Overview
        11.8.3 Abbott Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Abbott Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Abbott Recent Developments
    11.9 Emcure Pharmaceuticals
        11.9.1 Emcure Pharmaceuticals Corporation Information
        11.9.2 Emcure Pharmaceuticals Overview
        11.9.3 Emcure Pharmaceuticals Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Emcure Pharmaceuticals Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Emcure Pharmaceuticals Recent Developments
    11.10 Torrent Pharmaceuticals
        11.10.1 Torrent Pharmaceuticals Corporation Information
        11.10.2 Torrent Pharmaceuticals Overview
        11.10.3 Torrent Pharmaceuticals Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Torrent Pharmaceuticals Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Torrent Pharmaceuticals Recent Developments
    11.11 Biocon
        11.11.1 Biocon Corporation Information
        11.11.2 Biocon Overview
        11.11.3 Biocon Daclatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Biocon Daclatasvir Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Biocon Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Daclatasvir Industry Chain Analysis
    12.2 Daclatasvir Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Daclatasvir Production Mode & Process
    12.4 Daclatasvir Sales and Marketing
        12.4.1 Daclatasvir Sales Channels
        12.4.2 Daclatasvir Distributors
    12.5 Daclatasvir Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Daclatasvir Industry Trends
    13.2 Daclatasvir Market Drivers
    13.3 Daclatasvir Market Challenges
    13.4 Daclatasvir Market Restraints
14 Key Findings in The Global Daclatasvir Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Daclatasvir Market